NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 279 filers reported holding NEOGENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $2,241,026 | -23.4% | 139,454 | -17.0% | 0.01% | -20.0% |
| Q1 2023 | $2,924,184 | +60.9% | 167,960 | -20.4% | 0.01% | +42.9% |
| Q3 2022 | $1,817,000 | -13.7% | 210,992 | -18.4% | 0.01% | -12.5% |
| Q2 2022 | $2,106,000 | +28.4% | 258,443 | +91.4% | 0.01% | +60.0% |
| Q1 2022 | $1,640,000 | -36.2% | 134,999 | +79.2% | 0.01% | -28.6% |
| Q4 2021 | $2,570,000 | -23.8% | 75,331 | +7.8% | 0.01% | -30.0% |
| Q3 2021 | $3,371,000 | +6.9% | 69,886 | +0.1% | 0.01% | 0.0% |
| Q2 2021 | $3,152,000 | -6.9% | 69,791 | -0.6% | 0.01% | -16.7% |
| Q1 2021 | $3,385,000 | -15.1% | 70,193 | -5.3% | 0.01% | -14.3% |
| Q4 2020 | $3,989,000 | +37.4% | 74,085 | -5.9% | 0.01% | +16.7% |
| Q3 2020 | $2,904,000 | +13.6% | 78,724 | -4.6% | 0.01% | +9.1% |
| Q2 2020 | $2,556,000 | -1.2% | 82,519 | -11.9% | 0.01% | -15.4% |
| Q1 2020 | $2,587,000 | -5.6% | 93,708 | 0.0% | 0.01% | +30.0% |
| Q4 2019 | $2,741,000 | +37.9% | 93,708 | -9.9% | 0.01% | +25.0% |
| Q3 2019 | $1,988,000 | – | 104,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |